1st Qtrly 17-18 2nd Qtrly 17-18 3rd Qtrly 17-18 4th Qtrly 17-18 31st ANNUAL REPORT 2016-2017
1st Qtrly 16-17 2nd Qtrly 16-17 3rd Qtrly 16-17 4th Qtrly 16-17 30TH ANNUAL REPORT 2015-2016
1st Qtrly 15-16 2nd Qtrly 15-16 3rd Qtrly 15-16 4th Qtrly 15-16 29TH ANNUAL REPORT 2014-2015
1st Qtrly 14-15 2nd Qtrly 14-15 3rd Qtrly 14-15 4th Qtrly 14-15 28TH ANNUAL REPORT 2013-2014
1st Qtrly 13-14 2nd Qtrly 13-14 3rd Qtrly 13-14 4th Qtrly 13-14 27TH ANNUAL REPORT 2012-2013
1st Qtrly 12-13 2nd Qtrly 12-13 3rd Qtrly 12-13 4th Qtrly 12-13 26TH ANNUAL REPORT 2011-2012
1st Qtrly 11-12 2nd Qtrly 11-12 3rd Qtrly 11-12 4th Qtrly 11-12 25TH ANNUAL REPORT 2010-2011

COLINZ LABORATORIES LIMITED
A-101, Pratik Ind. Estate, Next to Fortis Hospital, Mulund-Goregaon Link Road, Mumbai - 400 078.

UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2014

  (Rupees in '000')
S. No. Particulars Un -audited Audited
Quarter Ended Year Ended
30.06.2014 31.03.2014 30.06.2013 31.03.2014
PART - I          
1 (a) Income from Operation        
    Gross Sales 22,278 18,213 20,712 77,960
    Less: Excise Duty 757 237 1,398 3,932
      Net Sales 21,521 17,976 19,314 74,028
  (b) Other Operating  Income  - - - -
  Total Income from Operation 21,521 17,976 19,314 74,028
2 Expenditure - - - -
  (a) Consumption of Materials 4,730 409 6,601 18,048
  (b) Purchase of Goods Traded 6,440 6,651 1,777 13,275
  (c) (Increase)/Decrease in stock in trade (787) 1,785 15 >2,012
  (d) Staff Cost 6,555 5,758 6,212 25,313
  (e) Depreciation 655 656 655 2,624
  (f) Other Expenditure 3,262 2,587 3,397 11,923
  Total Expenditure 20,855 17,846 18,657 73,195
3 Profit /Loss from Operation Before Other Income (1-2) 666 130 657 833
4 Other  Income /(Loss) 58 287 51 1,273
5 Profit /Loss before Interest & Exceptional items (3+4) 724 417 708 2,106
6 Interest 226 (125) 405 841
7 Profit /Loss  after Interest but before exceptional items (5-6) 498 542 303 1,265
8 Exceptional items  - - - -
9 Profit /Loss before Tax (7-8) 498 542 303 1,265
10 Tax Expenses (Provision for Taxation): Current tax (60) - - 229
                                                                Deffered tax (75) - - 371
             
11 Net Profit/Loss  after Tax (9-10) 363 542 303 665
12 Paid up Equity Share Capital (Face Value 10/- Per Share) 354,35 354,35 354,35 354,35
[Net of allotment money in arrears]
13 Reserves Excluding Revaluation Reserves  - - - 9,093
14 Earning per share (EPS) before extraordinary item (not Annualised) - - - -
  Basic & Diluted - - - 0.15
             
PART-II A. PARTICULARS  OF SHAREHOLDING         
1 Public Shareholding         
  i) Number of Shares 28,94,901 28,94,901 29,04,901 28,94,901
  ii) Percentage of shareholding  63.33% 63.33% 63.55% 63.33%
2 Promoters and promoter group Shareholding         
a) Pledged/Encumbered        
i) Number of shares - - - -
  ii) Percentage of shares (as a % of the total shareholding of - - - -
  promoter and promoter group)        
  iii) Percentage of shares (as a% of the total share capital of the company) - - - -
  b) Non-encumbered        
i) Number of Shares 16,76,099 16,76,099 16,66,099 16,76,099
  ii) Percentage of shares (as a% of the total shareholding) 36.67% 36.67% 36.45% 36.67%
   of promoter and promoter group)        
  iii) Percentage of shares (as a % of the total share capital of the company) 100% 100% 100% 100%

 

  B. INVESTORS COMPLAINTS 3 Months ended 30.06.14
  Pending at Begining of the Quarter  NIL
  Received During the Quarter NIL
  Disposed of During the Quarter NIL
  Remaining at the end of the Quarter NIL

 

NOTES :-
  1. 1. Theabove financial results have been taken on record at a meeting of Board of Directors held on 31-07-2014.
  2. The Company operates in single segment of manufacture of pharmaceutical formulations. Hence Accounting Standard on segment reporting is not applicable.
  3. Previous period figures have been regrouped wherever required.

 

  For and on behalf of the Board
  COLINZ LABORATORIES LIMITED
   
Mumbai Dr. L. S. Mani
31.07.2014 Chairman & Managing Director.

                                                                                                                     

(Top)

Contact:
A/101, Pratik Estate,
Mulund Link Road,
Next to Fortis Hospital,
Mumbai-400078.
Tel.: 91-22-25668002/3
Fax: 91-22-25668006.
Email: cllfindoc@yahoo.com
Website:www.findoc-cll.in
Email:info@findoc-cll.in